Bencianol is a semi-synthetic flavonoid compound with antispasmodic activity; it reverses contractions induced by 5-hydroxytryptamine, noradrenaline, angiotensin II, prostaglandin F2α, and the thromboxane-A2 mimetic U-46619 in a dose-dependent manner (1–100 μg/mL); it exhibits greater efficacy against EC50-induced contractions compared to maximal concentrations of each agent and is least effective against U-46619; additionally, it demonstrates cytoprotective effects against CCl4-induced cell injury at concentrations of 0.1–100 nM.